Comment: The Impact of Methodological Approach on Cost Findings in Comparison of Epoetin Alfa with Darbepoetin Alfa

Chen E , Peake C , Buscaino E . Hematologic outcomes and erythropoiesis-stimulating therapy costs in epoetin alfa (EPO) and darbepoetin alfa (DARB)–treated cancer patients: results of the Dosing and Outcomes Study of Erythropoiesis-Stimulating Therapies (D.O.S.E.) registry. Blood 2006; 109:953a.

Gosselin A , Lefebvre P , Duh MS , McKenzie SR , Mody SH , Piech CT . Dosing patterns and transfusion use in cancer patients treated with erythropoietic agents: results of an observational study of over 8,000 patients. Presented as a poster at the American Society of Hematology meetings, December 2005.

Berger A , Edelsberg J , Kallich J , Oster G . Use of darbepoetin alfa and epoetin alfa in clinical practice in patients with cancer-related anemia. Clin Ther 2008; 30:206–18.

Schwartzberg L , Shiffman R , Tomita D , Stolshek B , Rossi G , Adamson R . A multicenter retrospective cohort study of practice patterns and clinical outcomes of the use of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia. Clin Ther 2003; 25:2781–96.

Herrington JD , Davidson SL , Tomita DK , Green L , Smith RE , Boccia RV . Utilization of darbepoetin alfa and epoetin alfa for chemotherapy-induced anemia. Am J Health Syst Pharm 2005; 62:54–62.

Patton J , Reeves T , Wallace J . Effectiveness of darbepoetin alfa versus epoetin alfa in patients with chemotherapy-induced anemia treated in clinical practice. Oncologist 2004; 9:451–58.

Reed SD , Radeva JI , Daniel DB . Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial. Pharmacoeconomics 2006; 4:479–94.

Schwartzberg LS , Yee LK , Senecal FM . A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia in patients with breast, lung, or gynecologic cancer. Oncologist 2004; 9:696–707.

Glaspy J , Vadhan-Raj S , Patel R . Randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced anemia: the 20030125 Study Group Trial. J Clin Oncol 2006; 24:2290–7.